Expertise in
1
conditions

Thomas Kerforne

CHU De Poitiers
Poitiers, FR 
Expertise in
1
conditions
CHU De Poitiers
Poitiers, FR 

Overview

Thomas Kerforne practices practicing medicine in Poitiers, France.

Mr. Kerforne is highly rated in 1 condition, according to our data. His clinical expertise encompasses Cerebral Hypoxia, Ventricular Fibrillation, Hypothermia, Kidney Transplant, and Liver Transplant.

He is actively involved in clinical research, co-authoring 59 peer reviewed articles and participating in 7 clinical trials.

Gender

Male

Locations

CHU de Poitiers
Poitiers, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Psychological Impact of COVID-19 Outbreak on Caregivers Involved in Intensive Care Unit Patient Management: Impact on the Occurrence of Post-traumatic Stress Disorder, Anxiety, Depression and Burn Out Syndrome
Psychological Impact of COVID-19 Outbreak on Caregivers Involved in Intensive Care Unit Patient Management: Impact on the Occurrence of Post-traumatic Stress Disorder, Anxiety, Depression and Burn Out Syndrome
Enrollment Status: Completed
Publish Date: December 10, 2025
Intervention Type: Other
Pre-operative Carriage of Respiratory VIRUSes, and Acute Respiratory Distress Syndrome After Heart Surgery - VIRUS-ATTAC
Pre-operative Carriage of Respiratory VIRUSes, and Acute Respiratory Distress Syndrome After Heart Surgery - VIRUS-ATTAC
Enrollment Status: Completed
Publish Date: May 16, 2023
Intervention Type: Diagnostic test
Study Phase: Not Applicable
Comparison of Two Techniques of Renal Pre-transplant Infusion on the Evolution of Renal Function in the Recipient: Multicentre Randomized Trial
Comparison of Two Techniques of Renal Pre-transplant Infusion on the Evolution of Renal Function in the Recipient: Multicentre Randomized Trial
Enrollment Status: Completed
Publish Date: November 03, 2022
Intervention Type: Device
Dexmedetomidine After Cardiac Surgery for Prevention of Delirium: The Exactum Study a Randomised Double Blind Controlled Trial
Dexmedetomidine After Cardiac Surgery for Prevention of Delirium: The Exactum Study a Randomised Double Blind Controlled Trial
Enrollment Status: Completed
Publish Date: June 22, 2022
Intervention Type: Drug
Study Drugs: Dexmedetomidine, Sodium Chloride
Study Phase: Phase 3
Prospective Multi-centre Observational Study on the Epidemiology, Risk Factors and Consequences of Unexpected Cardiac Arrest in Intensive Care Units.
Prospective Multi-centre Observational Study on the Epidemiology, Risk Factors and Consequences of Unexpected Cardiac Arrest in Intensive Care Units.
Enrollment Status: Completed
Publish Date: August 17, 2020
Intervention Type: Other
Evaluation of Liver Grafts With FibroScan® Before Organ Retrieval in Patients With Brain Death
Evaluation of Liver Grafts With FibroScan® Before Organ Retrieval in Patients With Brain Death
Enrollment Status: Completed
Publish Date: October 24, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
Automatic Oxygen Administration in Early and Late Postoperative Hypoxaemia Prevention After Major Abdominal and Thoracic Surgery
Automatic Oxygen Administration in Early and Late Postoperative Hypoxaemia Prevention After Major Abdominal and Thoracic Surgery
Enrollment Status: Completed
Publish Date: January 16, 2019
Intervention Type: Device
Study Phase: Not Applicable
View 6 Less Clinical Trials

59 Total Publications

Dapagliflozin for cardiorenal protection after intensive care unit discharge: a protocol for a randomised controlled trial evaluating dapagliflozin at ICU discharge for cardiorenal protection (DAPA-ICU).
Dapagliflozin for cardiorenal protection after intensive care unit discharge: a protocol for a randomised controlled trial evaluating dapagliflozin at ICU discharge for cardiorenal protection (DAPA-ICU).
Journal: BMJ open
Published: April 16, 2026

Frequently Asked Questions about Thomas Kerforne

Is Thomas Kerforne a top-rated expert for Cerebral Hypoxia?

MediFind is an objective health platform that identifies experts based on real-world data. Thomas Kerforne is classified as an Advanced expert for Cerebral Hypoxia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Thomas Kerforne participate in research or clinical trials?

Yes. Thomas Kerforne has published 59 articles and abstracts on conditions like Cerebral Hypoxia. You can view a list of Thomas Kerforne's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kerforne's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile